flesinoxan has been researched along with Disease Models, Animal in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, MA; Morrison, KE | 1 |
| Miyagawa, K; Takeda, H; Tsuji, M | 1 |
| Bouwknecht, JA; Groenink, L; Olivier, B; Paylor, RE; van der Gugten, J | 2 |
| Ashby, CR; Feenstra, RW; Glennon, JC; Herremans, AH; Hesselink, MB; Kruse, CG; Li, Z; Long, SK; McCreary, AC; Meltzer, HY; Reinders, JH; van Stuivenberg, H | 1 |
| Di Francesco, GF | 1 |
| Chamienia, AL; Johns, EJ | 1 |
| Cryan, JF; Kelly, JP; Leonard, BE; Redmond, AM | 1 |
| Bruins Slot, LA; Colpaert, FC; Dupuis, DS; Koek, W | 1 |
| de Jongh, R; Groenink, L; Olivier, B; van Der Gugten, J | 1 |
10 other study(ies) available for flesinoxan and Disease Models, Animal
| Article | Year |
|---|---|
A role for 5-HT1A receptors in the basolateral amygdala in the development of conditioned defeat in Syrian hamsters.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Conditioning, Psychological; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mesocricetus; Molecular Targeted Therapy; Nerve Tissue Proteins; Neurons; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Stress, Psychological | 2012 |
Possible involvement of histone acetylation in the development of emotional resistance to stress stimuli in mice.
Topics: Acetylation; Analysis of Variance; Animals; Anti-Anxiety Agents; Diazepam; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Emotions; Epigenesis, Genetic; Gene Expression Regulation, Enzymologic; Histone Deacetylase Inhibitors; Histones; Hydroxamic Acids; Male; Mice; Mice, Inbred ICR; Piperazines; Stress, Physiological; Stress, Psychological; Time Factors | 2012 |
Behavioral and physiological mouse models for anxiety: effects of flesinoxan in 129S6/SvEvTac and C57BL/6J mice.
Topics: Animals; Anxiety; Darkness; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Lighting; Male; Mice; Mice, Inbred C57BL; Piperazines; Species Specificity | 2004 |
Effects of repeated testing in two inbred strains on flesinoxan dose-response curves in three mouse models for anxiety.
Topics: Animals; Anxiety; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Fever; Male; Mice; Mice, Inbred C57BL; Piperazines; Species Specificity | 2004 |
SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Binding, Competitive; Brain Chemistry; Catalepsy; CHO Cells; Columbidae; Cricetinae; Cricetulus; Discrimination, Psychological; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Piperazines; Rats; Rats, Wistar; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Transfection | 2007 |
Are the cardiovascular effects and '5-HT syndrome' induced by MDL 73,975 and flesinoxan in the dog mediated by 5-HT1A receptors?
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Behavior, Animal; Blood Pressure; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hypertension, Renal; Injections, Subcutaneous; Male; Piperazines; Prazosin; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Respiration; Serotonin Antagonists; Serotonin Receptor Agonists; Spiro Compounds; Tachyphylaxis | 1994 |
The cardiovascular and renal functional responses to the 5-HT1A receptor agonist flesinoxan in two rat models of hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Kidney; Male; Piperazines; Rats; Rats, Inbred SHR; Rats, Wistar | 1996 |
The effects of the 5-HT1A agonist flesinoxan, in three paradigms for assessing antidepressant potential in the rat.
Topics: Animals; Behavior, Animal; Depressive Disorder; Disease Models, Animal; Male; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists | 1997 |
Memory of an operant response and of depressed mood retained in activation states of 5-HT(1A) receptors: evidence from rodent models.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Behavior, Animal; Conditioning, Operant; Depression; Disease Models, Animal; Heterotrimeric GTP-Binding Proteins; Hippocampus; In Vitro Techniques; Ligands; Male; Memory; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming | 2000 |
The light-enhanced startle paradigm as a putative animal model for anxiety: effects of chlordiazepoxide, flesinoxan and fluvoxamine.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Chlordiazepoxide; Darkness; Disease Models, Animal; Fluvoxamine; Light; Male; Piperazines; Rats; Rats, Wistar; Reflex, Startle | 2002 |